GlobeNewswire
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update
📈
AI Sentiment
Highly Positive
8/10
Royalty Pharma plc News
Latest updates and market news for RPRX
5 news
Mar 22 - Mar 28, 2026
Page 1
Zacks
Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?
âž–
AI Sentiment
Neutral
4/10
Zacks
Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?
âž–
AI Sentiment
Neutral
5/10
StockStory
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q4 Earnings?
âž–
AI Sentiment
Neutral
4/10
GlobeNewswire
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
📈
AI Sentiment
Highly Positive
8/10
Share this news page